PBG BioPharma Inc. Announces the launch of a Phase 2/3 Clinical Trial on its Cannabinoid-based Drug Product ProZ-001 as an Adjunctive Therapy for Acute Bipolar Depression
- Feb 13, 2023
- 2 min
PBG BioPharma Inc. Successfully Files Cannabinoid Master Drug File to Health Canada
- Dec 12, 2022
- 2 min
PBG BioPharma achieves Food Safety System Certification (FSSC 22000)
- Sep 12, 2022
- 3 min
PBG BioPharma Inc. Announces Launch of GenBioChem® Line of Natural Health Products
- Mar 2, 2022
- 2 min
PBG BioPharma Inc. Receives Controlled Drug and Substances Dealer’s Licence
- Mar 2, 2022
- 2 min
PBG BioPharma Inc. Receives Cannabis 2.0 Sales Amendment to Health Canada Licence
- Sep 18, 2021
- 2 min
PBG BioPharma Inc. receives GMP Manufacturing Site Licence for NHPs
- Jun 7, 2021
- 2 min
PBG announces development of plant isolate PBG-007 as a potential Broad Spectrum Anti-viral
- Jun 2, 2021
- 2 min
PBG BioPharma Inc. donates nearly 1 million hand sanitizer bottles to Canadian communities
- Mar 23, 2021
- 1 min
PBG Biopharma Received its Cannabis Analytical Testing License from Health Canada
- Sep 4, 2020
- 2 min
PBG BioPharma announces the Official Completion of their Manufacturing and Research Laboratories
- Mar 10, 2020
- 3 min
GBC® Immunity is the first Canadian NHP successfully donated to first-line responders in Wuhan
- Jul 30, 2019
- 2 min
PBG BioPharma announces ribbon cutting ceremony for the opening of their new building
PARTNER WITH US
Got a project?
Let’s talk.
We’re a team of scientists who are excited about unique ideas and help cannabis companies realize their product vision.